12 articles for AK Chakraborti
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization.
Purdue University
3D-QSAR studies on thieno[3,2-d]pyrimidines as phosphodiesterase IV inhibitors.
National Institute of Pharmaceutical Education and Research (NIPER)
Comparative molecular field analysis (CoMFA) of phthalazine derivatives as phosphodiesterase IV inhibitors.
National Institute of Pharmaceutical Education and Research
Design, synthesis and biological evaluation of 5-benzylidene-2-iminothiazolidin-4-ones as selective GSK-3ß inhibitors.
National Institute of Pharmaceutical Education and Research
Design and synthesis of novel Y-shaped barbituric acid derivatives as PPAR¿ activators.
National Institute of Pharmaceutical Education and Research (NIPER)
2-(2-Arylphenyl)benzoxazole As a Novel Anti-Inflammatory Scaffold: Synthesis and Biological Evaluation.
National Institute of Pharmaceutical Education and Research (NIPER)
Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammatory agents.
National Institute of Pharmaceutical Education and Research (NIPER)
Three-dimensional quantitative structure (3-D QSAR) activity relationship studies on imidazolyl and N-pyrrolyl heptenoates as 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) inhibitors by comparative molecular similarity indices analysis (CoMSIA).
National Institute of Pharmaceutical Education and Research (NIPER)
New PPARgamma ligands based on barbituric acid: virtual screening, synthesis and receptor binding studies.
National Institute of Pharmaceutical Education and Research
New PPARgamma ligands based on 2-hydroxy-1,4-naphthoquinone: computer-aided design, synthesis, and receptor-binding studies.
National Institute of Pharmaceutical Education and Research
Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activities.
National Institute of Pharmaceutical Education and Research (NIPER)
